company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,112246000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,95358000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3494000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3970000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,215068000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2516000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,27586000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,220000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,27806000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,,totalassets,Total Assets,=,debit,usd,245390000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,21001000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,6696000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1673000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,29370000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,337000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1087000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1424000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,30794000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,456692000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-242060000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-36000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,214596000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,214596000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,214596000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q2,,2013-06-30,2013-08-14 17:29:08+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,245390000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,58710000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,116066000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,227000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3669000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,178672000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2428000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,44151000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,116000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,44267000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,,totalassets,Total Assets,=,debit,usd,225367000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,17477000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3930000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1863000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,23270000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3337000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,811000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,4148000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,27418000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,458495000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-260610000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,64000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,197949000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,197949000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,197949000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2013.0,Q3,,2013-09-30,2013-11-06 17:23:43+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,225367000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,63001000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,198433000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,6664000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5168000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,273266000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2670000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,44269000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,34000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,44303000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,,totalassets,Total Assets,=,debit,usd,320239000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,22370000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,8779000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1649000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,32798000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,17060000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1189000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,18249000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,51047000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,585563000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-316398000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,27000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,269192000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,269192000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,269192000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q1,,2014-03-31,2014-05-12 18:46:03+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,320239000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,57068000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,170857000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,182000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5009000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,233116000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2890000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,58002000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,6000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,58008000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,,totalassets,Total Assets,=,debit,usd,294014000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,25318000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,7719000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2273000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,35310000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,15706000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1102000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,16808000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,52118000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,589622000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-347748000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,22000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,241896000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,241896000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,241896000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q2,,2014-06-30,2014-08-06 17:27:26+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,294014000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,53144000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,172060000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,73000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4730000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,230007000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2732000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,36803000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,10007000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,46810000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,,totalassets,Total Assets,=,debit,usd,279549000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,12531000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,15284000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9875000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2498000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,40188000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,29123000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1006000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,30129000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,70317000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,592797000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-383541000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-24000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,209232000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,209232000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,209232000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2014.0,Q3,,2014-09-30,2014-11-10 17:10:52+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,279549000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,132846000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,258567000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,12000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,12025000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,403450000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3211000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,64960000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,14678000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,79638000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,,totalassets,Total Assets,=,debit,usd,486299000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5019000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,24761000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9335000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1678000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,40793000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,24892000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1639000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,26531000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,67324000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,888755000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-469710000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-70000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,418975000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,418975000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,418975000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q1,,2015-03-31,2015-05-06 18:55:22+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,486299000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,68911000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,332596000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,15967000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,417474000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4584000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,6091000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,13910000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,20001000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,,totalassets,Total Assets,=,debit,usd,442059000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,12625000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,24492000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9021000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2989000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,49127000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,22820000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2079000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,24899000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,74026000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,896162000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-528038000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-91000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,368033000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,368033000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,368033000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q2,,2015-06-30,2015-08-04 18:35:02+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,442059000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,77722000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,278246000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,20499000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,376467000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5406000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,12987000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,12987000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,,totalassets,Total Assets,=,debit,usd,394860000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9173000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,27439000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,8705000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,3841000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,49158000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,20726000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2068000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,22794000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,71952000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,906084000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-583196000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,20000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,322908000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,322908000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,322908000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2015.0,Q3,,2015-09-30,2015-11-09 16:33:35+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,394860000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,210704000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,262000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,210275000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,7500000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,14149000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,442890000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6779000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3151000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,11177000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,14328000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,,totalassets,Total Assets,=,debit,usd,463997000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,13281000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,20299000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,16938000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2709000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,53227000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,34570000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2660000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,37230000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,90457000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1084823000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-714276000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,66000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,370613000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,370613000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,2927000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,373540000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q1,,2016-03-31,2016-05-05 21:30:28+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,463997000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,139347000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,145000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,214215000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,27741000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,381448000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6819000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3151000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,16018000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,19169000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,,totalassets,Total Assets,=,debit,usd,407436000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4535000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,23872000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,17148000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,4635000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,50190000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,30879000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2455000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,33334000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,83524000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1092507000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-771615000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,93000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,320985000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,320985000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,2927000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,323912000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q2,,2016-06-30,2016-08-09 16:38:21+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,407436000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,98661000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,1930000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,175936000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5000000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,20171000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,301698000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6384000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3151000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,6316000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,9467000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,,totalassets,Total Assets,=,debit,usd,317549000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8993000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,17772000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,17148000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,3517000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,47430000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,26557000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2261000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,28818000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,76248000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1100981000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-864504000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,44000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,236521000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,236521000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,4780000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,241301000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2016.0,Q3,,2016-09-30,2016-11-07 17:20:49+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,317549000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,135669000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,174000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,182528000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,9210000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,327581000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5795000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3151000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4168000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,7319000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,,totalassets,Total Assets,=,debit,usd,340695000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9487000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,14452000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,20798000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,3399000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,48136000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,98288000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,19837000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,10707000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,128832000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,176968000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1121686000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-959980000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-91000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,161615000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,161615000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,2112000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,163727000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q1,,2017-03-31,2017-05-08 17:43:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,340695000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,123837000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,172000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,145861000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,15817000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,285687000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5576000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,8151000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,6277000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,14428000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,,totalassets,Total Assets,=,debit,usd,305691000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,11938000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,25088000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,15187000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,5560000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,57773000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,101744000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,21661000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,11146000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,134551000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,192324000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1140719000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1029634000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-70000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,111015000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,111015000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,2352000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,113367000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q2,,2017-06-30,2017-08-09 16:47:32+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,305691000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,344021000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,170000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,225107000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,10654000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,579952000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5614000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,28625000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,7996000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,9609000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,46230000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,,totalassets,Total Assets,=,debit,usd,631796000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,17463000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,28209000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,15187000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,8910000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,69769000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,104893000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,17833000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,10912000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,133638000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,203407000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1538650000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1112571000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-37000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,426042000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,426042000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,2347000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,428389000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2017.0,Q3,,2017-09-30,2017-11-08 20:52:06+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,631796000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,168414000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,47000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,240157000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1693000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,3248000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,18018000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,4660000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,436237000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5393000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,42514000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,7710000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4812000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,55036000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,,totalassets,Total Assets,=,debit,usd,496666000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,20788000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,27746000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3861000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,5113000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,57508000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,107397000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,5412000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,16181000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,128990000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,186498000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1568453000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1259660000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-801000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,307992000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,307992000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,2176000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,310168000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q1,,2018-03-31,2018-05-10 16:45:17+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,496666000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,173052000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,30000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,262836000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3421000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,7082000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,25970000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,6491000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,478882000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5358000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,20777000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,7567000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,14000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,28358000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,,totalassets,Total Assets,=,debit,usd,512598000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,5971000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6746000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,46471000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,4928000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,7463000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,71579000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,200236000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,5194000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,15528000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,220958000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,292537000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1584210000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1365853000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-674000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,217683000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,217683000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,2378000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,220061000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q2,,2018-06-30,2018-08-09 16:02:19+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,512598000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,146700000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,272000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,223284000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,7150000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,6123000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,10291000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,9872000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,403692000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4921000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,10881000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,7423000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,20788000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,39092000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,,totalassets,Total Assets,=,debit,usd,447705000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,9395000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,15163000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,25968000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2358000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,8197000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,61081000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,201749000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,5085000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,12862000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,219696000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,280777000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1602017000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1437156000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-437000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,164424000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,164424000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,2504000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,166928000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2018.0,Q3,,2018-09-30,2018-11-07 16:40:48+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,447705000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,226793000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,1528000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,96048000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,11787000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,2672000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,9713000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,6317000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,354858000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5032000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,7137000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,33355000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,40492000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,,totalassets,Total Assets,=,debit,usd,400382000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,15079000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9748000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,46789000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2212000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,73828000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,260625000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,4426000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,10853000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,275904000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,349732000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1652362000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1603860000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-80000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,48422000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,48422000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,2228000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,50650000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q1,,2019-03-31,2019-05-08 08:36:47+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,400382000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,185385000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,2280000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,88553000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,13955000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1547000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,9408000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,4795000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,305923000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4769000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,3844000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,51953000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,55797000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,,totalassets,Total Assets,=,debit,usd,366497000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,19567000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,11832000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,51641000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1267000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,84307000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,259159000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,4415000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,18022000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,281596000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,365903000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1670697000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1670064000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-39000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,594000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,594000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,594000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q2,,2019-06-30,2019-08-07 16:30:59+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,366497000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,304265000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,3201000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,172542000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,18236000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,2357000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,10106000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,3788000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,514495000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4561000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,3699000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,54434000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,58133000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,,totalassets,Total Assets,=,debit,usd,577185000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,24189000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,13760000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,48481000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1061000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,87491000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,256379000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,4399000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,16028000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,276806000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,364297000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1932507000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1719691000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,72000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,212888000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,212888000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,0.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,212888000.0
Portola Pharmaceuticals Inc,PTLA,549300BM3O4O0CNBGJ64,0001269021,2019.0,Q3,,2019-09-30,2019-11-05 17:10:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,577185000.0
